16 Hrs
Source:
Financial Times
GE HealthCare discusses $1bn cancer chemical deal
Sofie Biosciences was acquired in a notable purchase by a medical imaging specialist, marking the company's second major acquisition following its split from General Electric.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)